BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27896425)

  • 1. Probability and pattern of occult cervical lymph node metastases in primary parotid carcinoma.
    Stodulski D; Mikaszewski B; Majewska H; Wiśniewski P; Stankiewicz C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1659-1664. PubMed ID: 27896425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of lymph node metastasis of parotid cancer.
    Shinomiya H; Otsuki N; Yamashita D; Nibu K
    Auris Nasus Larynx; 2016 Aug; 43(4):446-50. PubMed ID: 26656731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of lymph node metastasis and the management of neck dissection for parotid carcinomas: a single-institute experience.
    Jinnin T; Kawata R; Higashino M; Nishikawa S; Terada T; Haginomori SI
    Int J Clin Oncol; 2019 Jun; 24(6):624-631. PubMed ID: 30739264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective neck dissection in primary parotid carcinomas: A systematic review and meta-analysis.
    Borsetto D; Iocca O; De Virgilio A; Boscolo-Rizzo P; Phillips V; Nicolai P; Spriano G; Fussey J; Di Maio P
    J Oral Pathol Med; 2021 Feb; 50(2):136-144. PubMed ID: 33222323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting occult lymph node metastasis in parotid cancer.
    Frankenthaler RA; Byers RM; Luna MA; Callender DL; Wolf P; Goepfert H
    Arch Otolaryngol Head Neck Surg; 1993 May; 119(5):517-20. PubMed ID: 8484940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of intraglandular lymph node metastases in primary carcinomas of the parotid gland.
    Nisa L; Salmina C; Dettmer MS; Arnold A; Aebersold DM; Borner U; Giger R
    Laryngoscope; 2015 Sep; 125(9):2099-106. PubMed ID: 25946394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of surgical treatment of lymph node metastases in patients with cutaneous squamous cell carcinoma of the head and neck.
    León X; López S; Pérez M; Valero C; Holgado A; Quer M; Vega C
    Acta Otorrinolaringol Esp (Engl Ed); 2024; 75(3):169-176. PubMed ID: 38224869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of neck dissection in patients with cancer of the parotid gland and a clinical NO neck.
    Teymoortash A; Werner JA
    Onkologie; 2002 Apr; 25(2):122-6. PubMed ID: 12006762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
    Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
    Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limited role of elective neck dissection in patients with cN0 salivary gland carcinoma.
    Qian K; Guo K; Zheng X; Sun W; Sun T; Chen L; Ma D; Wu Y; Ji Q; Wang Z
    J Craniomaxillofac Surg; 2019 Jan; 47(1):47-52. PubMed ID: 30528947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for elective neck dissection in malignant epithelial parotid tumors].
    Redaelli de Zinis LO; Piccioni LO; Ghizzardi D; Mantini G; Antonelli AR
    Acta Otorhinolaryngol Ital; 1998 Feb; 18(1):11-5. PubMed ID: 9707725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of cervical lymph node metastasis in medial wall pyriform sinus carcinoma.
    Chung EJ; Lee SH; Baek SH; Park IS; Cho SJ; Rho YS
    Laryngoscope; 2014 Apr; 124(4):882-7. PubMed ID: 23832757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas.
    Régis De Brito Santos I; Kowalski LP; Cavalcante De Araujo V; Flávia Logullo A; Magrin J
    Arch Otolaryngol Head Neck Surg; 2001 Jan; 127(1):56-60. PubMed ID: 11177015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between wait-and-see policy and elective neck dissection in clinically N0 cutaneous squamous cell carcinoma of head and neck.
    Xiao Y; Yuan S; Liu F; Liu B; Zhu J; He W; Li W; Kan Q
    Medicine (Baltimore); 2018 Jun; 97(22):e10782. PubMed ID: 29851784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of bilateral cervical metastases in oropharyngeal squamous cell carcinoma: a retrospective analysis of 352 cases after bilateral neck dissection.
    Olzowy B; Tsalemchuk Y; Schotten KJ; Reichel O; Harréus U
    Head Neck; 2011 Feb; 33(2):239-43. PubMed ID: 20848445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for and extent of elective neck dissection for lymph node metastasis from external auditory canal carcinoma.
    Kiyokawa Y; Ariizumi Y; Ohno K; Ito T; Kawashima Y; Tsunoda A; Kishimoto S; Asakage T; Tsutsumi T
    Auris Nasus Larynx; 2021 Aug; 48(4):745-750. PubMed ID: 33386189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance and Indication for Surgical Treatment of Occult Cervical and Intraglandular Nodal Involvement in Parotid Malignancy.
    Ketterer MC; Konrad Dahlem KK; Häussler SM; Jakob TF; Pfeiffer J; Becker C
    J Oral Maxillofac Surg; 2019 Nov; 77(11):2355-2361. PubMed ID: 31077673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological study on patterns of cervical lymph node metastases from squamous cell carcinomas (SCC) of the head and neck].
    Li X; Li L; Wei W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):206-9. PubMed ID: 9642343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.